These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4114753)

  • 61. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Advanced lung cancer treated with cyclophosphamide.
    Davis HL; Ramirez G; Korbitz BC; Ansfield FJ
    Dis Chest; 1969 Dec; 56(6):494-500. PubMed ID: 4187520
    [No Abstract]   [Full Text] [Related]  

  • 63. [The role of selective bronchial arterial infusion in the comprehensive treatment of advanced bronchial carcinoma].
    Sun SL
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Oct; 12(5):286-7, 319. PubMed ID: 2561087
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chemotherapy for lung cancer.
    Perevodchikova NI
    Cancer Treat Rep; 1976 Oct; 60(10):1479-81. PubMed ID: 191187
    [No Abstract]   [Full Text] [Related]  

  • 65. [Chemotherapy-cum-radiotherapy-cum-surgery in the treatment of small-cell bronchogenic carcinoma (author's transl)].
    Gatzemeier U
    Prax Klin Pneumol; 1980 Feb; 34(2):102-7. PubMed ID: 7378158
    [No Abstract]   [Full Text] [Related]  

  • 66. Intensive induction treatment of small cell bronchogenic carcinoma with cyclophosphamide, methotrexate, and etoposide.
    Bonomi P; O'Reilly W; Vogl SE; Ruckdeschel JC; Stolbach L; Bunting N; Creech RH
    Cancer Treat Rep; 1985 Sep; 69(9):1007-9. PubMed ID: 2992783
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical evaluation of procarbazine and fluorouracil in advanced lung cancer.
    Pacilio G; Puzziello T
    Bronches; 1971; 21(4):402. PubMed ID: 4340778
    [No Abstract]   [Full Text] [Related]  

  • 68. Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan.
    Bonadonna G; Tancini G; Bajetta E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):231-7. PubMed ID: 4125741
    [No Abstract]   [Full Text] [Related]  

  • 69. CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung.
    Cambareri RJ; Smith FP; Macdonald JS; Haidak DJ; Ueno WM; Hoth DH; Woolley PV; Schein PS
    Cancer Treat Rep; 1981; 65(3-4):317-20. PubMed ID: 6263471
    [No Abstract]   [Full Text] [Related]  

  • 70. [Clinical experiences with long term chemo therapy of spinocellular bronchogenic carcinoma].
    Zapletal J
    Cas Lek Cesk; 1969 May; 108(23):688-90. PubMed ID: 4977649
    [No Abstract]   [Full Text] [Related]  

  • 71. Therapy of bronchogenic carcinoma with the drug platidiam lachema.
    Kolek V; Kroutilová J; Minarík J; Zák J
    Acta Univ Palacki Olomuc Fac Med; 1986; 114():275-83. PubMed ID: 3022563
    [No Abstract]   [Full Text] [Related]  

  • 72. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J; Saiz García F
    Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
    [No Abstract]   [Full Text] [Related]  

  • 73. [Treatment of patients with lung cancer with a combination of nitrosomethylurea and cyclophosphane].
    Perevodchikova NI; Korman NP; Bychkov MB
    Vopr Onkol; 1975; 21(8):21-5. PubMed ID: 170742
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An analysis of comparative trails of L-asparaginase (NSC-109929), cyclophosphamide and placebo in patients with inoperable bronchogenic carcinoma using corrected survival estimates.
    Brindley CO; Griffin JP; Williams JS; Wolf J
    Oncology; 1978; 35(1):33-8. PubMed ID: 343025
    [No Abstract]   [Full Text] [Related]  

  • 75. Treatment of non-small cell bronchogenic carcinoma with vinblastine and mitomycin: a Southwest Oncology Group Study.
    Weick JK; Rainey JM; Livingston RB; Baker LH; O'Bryan RM; Chen TT
    Cancer Treat Rep; 1985 Jun; 69(6):583-5. PubMed ID: 2990709
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
    Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
    Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
    Cohen MH; Ihde DC; Bunn PA; Fossieck BE; Matthews MJ; Shackney SE; Johnston-Early A; Makuch R; Minna JD
    Cancer Treat Rep; 1979 Feb; 63(2):163-70. PubMed ID: 221114
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Evaluation of the results of chemotherapy in squamous cell bronchial carcinoma].
    Nagorni-Obradović L
    Med Pregl; 1991; 44(9-10):387-90. PubMed ID: 1806789
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Cancer chemotherapy as a supplement to operation in bronchogenic carcinoma].
    Castberg T; Kruse-Blinkenberg HO
    Ugeskr Laeger; 1976 Jun; 138(24):1449-55. PubMed ID: 1273973
    [No Abstract]   [Full Text] [Related]  

  • 80. 5-Fluorouracil (NSC-19893) compared to cyclophosphamide (NSC-26271) in bronchogenic carcinoma: results of a clinical study.
    Brugarolas A; Rivas A; Lacave AJ; Gonzalez-Palacois F; Froufe A
    Cancer Chemother Rep; 1975; 59(5):1025-6. PubMed ID: 1106844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.